Some quick data for the Pharmaceutical Industry in Malaysia:
Pharmaceutical Market, 2011: RM 4.4 billion
Government 51%
Private Clinic 19%
Private Hospital 17%
Pharmacy 13%
Government Purchases in 2011
RM 588 mil Patents
RM 862 mil Generics
Leverage patent expiry cliff by pursuing generic opportunities. Value globally at USD 150 billion in 2015
Malaysia:
- A member of the Pharmaceutical Inspection Co-operation Scheme (PICS)
- Off-take Procurement Agreement for New Locally Manufactured Pharmaceuticals for 3+2 years
- Fast-track registrations for new products under EPP3 in the NKEA programme
- Compulsory service for pharmacists reduced from three years to one. Pupillage allowed in the private sector/industry
- All generics are subjected to BE Studies and their labs are inspected for compliance
- Strengthening patent related issues on pharmaceuticals
- Improve the collection and management of pharmaceutical data with IMS
- Improve market access into foreign countries
(Acknowledgement with thanks: Sources - IMS, Ministry of Health, PEMANDU)
Post a Comment